car-t research from dana-farber in follicular lymphoma and marginal zone lymphoma
Published 4 years ago • 267 plays • Length 1:55Download video MP4
Download video MP3
Similar videos
-
2:48
cancer research: fda approves car t-cell therapy for indolent follicular lymphoma
-
2:25
car-t cost effectiveness study | dana-farber cancer institute
-
1:19
toxicity profile of car t-cell therapy appears safe in follicular and marginal zone lymphomas
-
37:17
lymphoma clinical trials and new treatment options | dana-farber cancer institute
-
1:31
dana-farber cancer institute: caron jacobson, md ash 2020
-
26:05
maintenance therapy for lymphoma | dana-farber cancer institute
-
2:44
what is car t-cell therapy? | dana-farber cancer institute
-
2:07
hodgkin lymphoma: new research by dana-farber cancer institute
-
1:12
ann lacasce, md, on car t-cell therapy
-
0:17
did you know: what’s in a dose of car t-cell therapy?
-
2:21
car t-cell therapy: how does it work?
-
11:55
a virtual tour of dana-farber cancer institute – longwood campus
-
10:21
advances in car-t therapy for lymphoma
-
0:25
what’s next in car t-cell therapy?
-
45:11
how is radiation therapy used to treat lymphoma? | dana-farber cancer institute
-
11:11
diffuse large cell lymphoma: treatment and side effects | dana-farber cancer institute
-
1:33
car t-cell therapy approved for mantle cell lymphoma
-
29:13
facebook live: car t-cell therapy and lymphoma
-
2:46
advances in lymphoma: a patient's journey